Impact of baseline kidney function on the effects of sodium-glucose co-transporter-2 inhibitors on kidney and heart failure outcomes: A systematic review and meta-analysis of randomized controlled trials.

Ernesto Maddaloni,Ilaria Cavallari,Ylenia La Porta,Alessandro Appetecchia,Luca D'Onofrio,Francesco Grigioni,Raffaella Buzzetti,Rury R Holman

Diabetes, obesity & metabolism（2023）

引用 5|浏览17

暂无评分

摘要

SGLT2is reduce the risk of renal and HF outcomes for all eGFR categories. The greatest benefits in terms of kidney protection may be achieved by early initiation of SGLT2is in people with preserved eGFR. The greatest risk reduction for HF outcomes is observed in people with lower eGFR values.

查看译文

关键词

SGLT2is,cardiovascular outcomes,heart failure,kidney disease,kidney failure

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要